What is the appropriate evaluation and management for a 14-year-old presenting with fever, mild jaundice, and abdominal pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Evaluation and Management of a 14-Year-Old with Fever, Mild Jaundice, and Abdominal Pain

Begin with abdominal ultrasound as the initial imaging modality and obtain a comprehensive hepatic panel including viral hepatitis serologies (HAV IgM, HBV, HCV, EBV, HEV), complete blood count, liver transaminases, conjugated/unconjugated bilirubin, alkaline phosphatase, and coagulation studies to differentiate between infectious hepatitis and biliary obstruction. 1

Initial Diagnostic Approach

In a 14-year-old presenting with this triad, the differential diagnosis centers on:

  • Viral hepatitis (HAV, HEV, EBV) - most common in this age group
  • Acute cholecystitis/cholangitis (including acalculous cholecystitis)
  • Severe malaria (if travel history to endemic areas)
  • Drug-induced hepatotoxicity

Critical Initial Assessment

Immediately assess for high-risk features that indicate severe disease 2:

  • Depressed consciousness (any degree)
  • Active seizures
  • Hypoxia (O2 saturation <95%)
  • Shock (systolic BP <80 mmHg, tachycardia, cool peripheries, capillary refill ≥3 seconds)
  • Hypoglycemia (<3 mmol/L)
  • Metabolic acidosis (base deficit >8 mmol/L)

If any high-risk features are present, this constitutes a medical emergency requiring immediate supportive treatment and ICU-level monitoring.

Laboratory Evaluation

Order the following tests immediately 1, 3:

  1. Hepatic panel: Total/direct bilirubin, AST, ALT, alkaline phosphatase, GGT, total protein, albumin
  2. Synthetic function: PT/INR, PTT
  3. Complete blood count with differential (look for thrombocytopenia, anemia)
  4. Viral serologies: Anti-HAV IgM, anti-HEV IgM, EBV VCA IgM, HBsAg, anti-HCV
  5. Blood, urine cultures if fever present 4, 5
  6. Electrolytes, creatinine, glucose

The pattern of liver enzyme elevation helps categorize the jaundice:

  • Hepatocellular pattern: AST/ALT >5x upper limit normal, alkaline phosphatase <2x normal (suggests viral hepatitis)
  • Cholestatic pattern: Alkaline phosphatase >2x normal, AST/ALT <5x normal (suggests biliary obstruction)

Imaging Strategy

Start with abdominal ultrasound 1, 4, 5:

Ultrasound is the appropriate initial imaging because it:

  • Detects biliary ductal dilatation (sensitivity 32-100% for obstruction)
  • Identifies gallbladder pathology including acalculous cholecystitis
  • Shows characteristic "starry sky" liver appearance in viral hepatitis 6
  • Avoids radiation exposure in adolescents
  • Is readily available and cost-effective

Look for specific ultrasound findings:

  • Gallbladder wall thickening, pericholecystic fluid (acalculous cholecystitis) 7
  • Biliary ductal dilatation (>6mm common bile duct)
  • Porta hepatis/pancreatic head lymphadenopathy (EBV-related) 8
  • Altered liver echogenicity with "starry sky" pattern (viral hepatitis) 6

If ultrasound is equivocal and clinical suspicion for biliary obstruction persists, obtain abdominal MRI/MRCP as subsequent imaging 4, 5. MRCP is superior to CT in adolescents because it avoids radiation and better delineates biliary anatomy without contrast.

Specific Clinical Scenarios

If Viral Hepatitis is Confirmed

HAV/HEV co-infection 6:

  • Supportive care: IV fluids, antiemetics, nutritional support
  • Monitor liver function tests every 2-3 days
  • Watch for coagulopathy (check PT/INR)
  • Expect resolution within 2-4 weeks
  • No specific antiviral therapy needed

EBV hepatitis 8, 9:

  • May present with cholestatic pattern and elevated CA 19-9 (transient, not malignant)
  • Porta hepatis lymphadenopathy can mimic biliary obstruction
  • Conservative management with close monitoring
  • Symptoms typically resolve within 1-2 weeks
  • Check for associated splenomegaly, lymphadenopathy

If Acute Cholecystitis/Cholangitis is Suspected

Diagnostic criteria for acute cholangitis 4, 5:

  • Clinical: Jaundice + fever + right upper quadrant pain
  • Laboratory: Elevated inflammatory markers + biliary stasis markers
  • Imaging: Biliary dilatation or evidence of obstruction (stone, stricture, mass)

Management:

  • Obtain blood, urine cultures before antibiotics 4
  • Start broad-spectrum antibiotics
  • Surgical consultation for potential cholecystectomy
  • ERCP if choledocholithiasis confirmed

If Malaria is Possible (Travel History)

Intermediate risk features requiring high-dependency care 2:

  • Hemoglobin <100 g/L
  • History of convulsions
  • Hyperparasitemia >5%
  • Visible jaundice
  • P. falciparum in patient with sickle cell disease

Obtain thick and thin blood films (three negative films 12 hours apart to exclude). Start antimalarial therapy immediately if positive.

Common Pitfalls to Avoid

  1. Do not assume viral hepatitis without imaging - acalculous cholecystitis can present identically and requires different management 7

  2. Do not obtain CT as initial imaging - ultrasound is equally effective and avoids radiation in adolescents 1, 4, 5

  3. Do not miss EBV-related cholestasis - elevated CA 19-9 and porta hepatis lymphadenopathy can mimic malignancy but resolve with conservative care 8

  4. Do not delay cultures if fever present - obtain blood and urine cultures before starting antibiotics, even without obvious infection 4

  5. Monitor coagulation studies - hepatitis can cause coagulopathy requiring vitamin K supplementation 9

Monitoring and Follow-up

  • Daily monitoring of liver function tests, bilirubin, PT/INR during acute phase
  • Clinical reassessment every 24-48 hours for worsening symptoms
  • Repeat ultrasound at 1 week if initial findings were equivocal
  • Outpatient follow-up at 2 weeks with repeat liver function tests to confirm normalization 6, 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.